CAS: 14028-44-5; 2-Chloro-11-(Piperazin-1-yl)Dibenzo[b,F][1,4]Oxazepine

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号1977-10-2 洛沙平 | CAS号3158-91-6 2-氯二苯并[b,f][1,4... | CAS号110-85-0 哌嗪 | CAS号3455-14-9 2,11-二氯二苯并[b,f]...

合成工艺路线路线简述

    洛沙平置于盐酸,N,N-二甲基苯胺,三氯氧磷体系中,用 Xylene 用作溶剂,化学反应 26.0H,反应生成阿莫沙平
    参考文献:在11-Stellung氨基取代基dibenzo [b,F]-1,4-Thiazepine和-Oxazepine中使用über.9. Mitteilungübersiebengliedrige杂环†
    标题:在11-Stellung氨基取代基dibenzo [b,F]-1,4-Thiazepine和-Oxazepine中使用über.9. Mitteilungübersiebengliedrige杂环†
    摘要:在11-氨基取代的二苯并[b,F]-1,4-噻氮平和二苯并[b,F]-1,4-氧杂氮平系列iii中发现了抗精神病药.它们可以通过亚氨基氯化物vi的氨解和/或尿素ii的bischler-Napieralski用pocl 3闭环合成.
    Doi:10.1002/hlca.19670500131

    海关参考信息

    专利信息


    专利号:US-9353057-B2
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
    发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
    权利人:XENOPORT INC
    摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-10005720-B2
    优先权日:2013-04-05
    标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same
    发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L
    权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL
    摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.

    专利号:US-9315483-B2
    优先权日:2007-09-13
    标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof
    发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT
    权利人:CONCERT PHARMACEUTICALS INC
    摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.

    专利号:US-12234200-B2
    优先权日:2019-04-16
    标 题:Synthetic methods of preparing esketamine
    发明人:CHEN CHENG YI
    权利人:JANSSEN PHARMACEUTICA NV
    摘要:The present invention is directed to methods for the asymmetric synthesis of esketamine. The present invention is further directed to key intermediates in the asymmetric esketamine synthesis. In one embodiment, the invention is an asymmetric synthesis of esketamine comprising the conversion of (S)-2′-chloro-2-methoxy-3,4,5,6-5 tetrahydro-[1, 1′-biphenyl]-3-yl carbamate to (S)-2′-chloro-1-isocyanato-6-methoxy-1,2,3,4-tetrahydro-1,1′-biphenyl.

    专利号:US-12180182-B2
    优先权日:2021-12-01
    标题 :(Di)amination of activated allene compounds, derivatives thereof, and methods for synthesis of the same
    发明人:DAI MINGJI
    权利人:PURDUE RESEARCH FOUNDATION
    摘要:One-pot synthesis methods for producing amines from activated allenes and derivatives thereof are provided, as well as the compounds produced thereby.
    台州市星明药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xm-chem.com
    企业联系电话:0576-88516108;88582618👤
    📞台州市星明药业有限公司 ⚠️参考联系方式

    电话:0576-88516108;88582618

    传真:0576-88582603
    邮箱:sales@xm-chem.com
    通信地址: 浙江省台州市椒江区滨海路89号
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省台州市椒江区滨海路89号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    浙江奥翔药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ausunpharm.com
    企业联系电话:0576-85589335👤
    📞浙江奥翔药业股份有限公司 ⚠️参考联系方式
    联系人:陶经理
    电话:0576-85589335

    传真:0086-576-85589168
    邮箱:sales@ausunpharm.com
    通信地址: 浙江省化学原料药基地临海园区东海第四大道5号
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省化学原料药基地临海园区东海第四大道5号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Amoxapine. 2022 Apr 18. 2012–. Amoxapine. 2016 Mar 2. 2023 Jan–. 16(3):199-204. doi: 10.1177/106002808201600302. 1(5):417-24. 15(3):166-70. doi: 10.1159/000468433. 52(6):657-661. doi: 10.1016/j.pjnns.2018.07.005. Epub 2018 Aug 11. 251(5):601-3. 24(1):1-23. doi: 10.2165/00003495-198224010-00001. 17(3):274-8. doi: 10.1016/s0196-0644(88)80122-7. 51(4):327. doi: 10.4103/0019-5545.58305.
    12: Drugs for Depression. Med Lett Drugs Ther. 2020 Feb 24;62(1592):25-32. 140(6):820. doi: 10.1176/ajp.140.6.820a. 20(1):308. doi: 10.1186/s12888-020-02711-z.
    15: Wang J, Sha J, Strong E, Chopra AK, Lee S. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy. Microbiol Spectr. 2022 Oct 26;10(5):e0250922. doi: 10.1128/spectrum.02509-22. Epub 2022 Sep 21.

    合成参考文献


    参考文献:10.1007/s10549-005-9056-0
    摘要:Chien C, Li CI, Heckbert SR, Malone KE, Boudreau DM, Daling JR. Antidepressant use and breast cancer risk. Breast Cancer Research and Treatment. 2005 Dec 02;95(2):131–40. doi: 10.1007/s10549-005-9056-0.
    参考文献:10.1007/s00535-005-1687-8
    摘要:Hojo M, Miwa H, Yokoyama T, Ohkusa T, Nagahara A, Kawabe M, Asaoka D, Izumi Y, Sato N. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol. 2005 Nov;40(11):1036–42. doi: 10.1007/s00535-005-1687-8.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知